Randomised evaluation of treatment modalities in thromboembolic disorders.
ten Cate
J W
JW
Division of Vascular Medicine, Academic Medical Center, Amsterdam, The Netherlands. c.c.Keyzers@amc.uva.nl
Büller
H R
HR
D000553:Ambulatory Care; D000925:Anticoagulants / Q000008:administration & dosage / Q000627:therapeutic use*; D015331:Cohort Studies; D003374:Coumarins / Q000008:administration & dosage / Q000627:therapeutic use; D004311:Double-Blind Method; D004334:Drug Administration Schedule; D005500:Follow-Up Studies; D006493:Heparin / Q000008:administration & dosage / Q000627:therapeutic use; D006495:Heparin, Low-Molecular-Weight / Q000008:administration & dosage / Q000627:therapeutic use; D006760:Hospitalization; D006801:Humans; D015994:Incidence; D015995:Prevalence; D011446:Prospective Studies; D016032:Randomized Controlled Trials as Topic; D012008:Recurrence; D013923:Thromboembolism / Q000188:drug therapy* / Q000453:epidemiology / Q000517:prevention & control
D000925:Anticoagulants; D003374:Coumarins; D006495:Heparin, Low-Molecular-Weight; D006493:Heparin